Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells

Experimental Cell Research

Volumn 322, Issue 2, 2014, Pages 249-264

  Ranjan, Amit ^a   Bane, Sanjay M ^a   Kalraiya, Rajiv D ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Basement membrane; Integrin 3 1; Invasion; Metastasis; Tetraspanin CD151; 1,6 branched N linked oligosaccharides

Indexed keywords

CD151 ANTIGEN; FIBRONECTIN; FIBRONECTIN ALPHA5 BETA1; GELATINASE B; LAMININ; LAMININ ALPHA3 BETA1; LAMININ RECEPTOR; MATRIGEL; OLIGOSACCHARIDE; TETRASPANIN; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; BIODEGRADATION; CELL ADHESION; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CELL SURFACE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GLYCOSYLATION; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SURFACE PROPERTY; TUMOR INVASION;

BASEMENT MEMBRANE; INTEGRIN Α3Β1; INVASION; METASTASIS; TETRASPANIN CD151; Β1,6 BRANCHED N-LINKED OLIGOSACCHARIDES;

ANIMALS; ANTIGENS, CD151; BASEMENT MEMBRANE; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; FIBRONECTINS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; INTEGRIN ALPHA3BETA1; INTEGRIN ALPHA5BETA1; LAMININ; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, LAMININ; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84896038546     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.02.004     Document Type: Article

References (59)

1. Spano D., Heck C., De Antonellis P., Christofori G., Zollo M. Molecular networks that regulate cancer metastasis. Semin. Cancer Biol. 2012, 22:234-249.
2. Steeg P.S. Invasion and metastasis. Curr. Opin. Oncol. 1992, 4:134-141.
3. Cairns R.A., Khokha R., Hill R.P. Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr. Mol. Med. 2003, 3:659-671.
4. Fidler I.J. The organ microenvironment and cancer metastasis. Differentiation 2002, 70:498-505.
5. Brooks S.A., Lomax-Browne H.J., Carter T.M., Kinch C.E., Hall D.M. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010, 112:3-25.
6. Fidler I.J., Kim S.J., Langley R.R. The role of the organ microenvironment in the biology and therapy of cancer metastasis. J. Cell. Biochem. 2007, 101:927-936.
7. Luzzi K.J., MacDonald I.C., Schmidt E.E., Kerkvliet N., Morris V.L., Chambers A.F., Groom A.C. Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 1998, 153:865-873.
8. Stetler-Stevenson W.G., Liotta L.A., Kleiner D.E. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 1993, 7:1434-1441.
9. Dennis J.W., Laferte S., Waghorne C., Breitman M.L., Kerbel R.S. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987, 236:582-585.
10. Yagel S., Feinmesser R., Waghorne C., Lala P.K., Breitman M.L., Dennis J.W. Evidence that beta 1-6 branched Asn-linked oligosaccharides on metastatic tumor cells facilitate invasion of basement membranes. Int. J. Cancer 1989, 44:685-690.
11. Yanagi M., Aoyagi Y., Suda T., Mita Y., Asakura H. N-Acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2001, 16:1282-1289.
12. Zhao Y.Y., Takahashi M., Gu J.G., Miyoshi E., Matsumoto A., Kitazume S., Taniguchi N. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 2008, 99:1304-1310.
13. Dennis J.W., Granovsky M., Warren C.E. Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1999, 1473:21-34.
14. Yamamoto H., Swoger J., Greene S., Saito T., Hurh J., Sweeley C., Leestma J., Mkrdichian E., Cerullo L., Nishikawa A., Ihara Y., Taniguchi N., Moskal J.R. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res. 2000, 60:134-142.
15. Tomiie M., Isaka S., Miyoshi E., Taniguchi N., Kimura T., Ogita K., Tsutsui T., Shimoya K., Nakagawa T., Kondo A., Koyama M., Murata Y. Elevated expression of N-acetylglucosaminyltransferase V in first trimester human placenta. Biochem. Biophys. Res. Commun. 2005, 330:999-1004.
16. Pili R., Chang J., Partis R.A., Mueller R.A., Chrest F.J., Passaniti A. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Cancer Res. 1995, 55:2920-2926.
17. Fernandes B., Sagman U., Auger M., Demetrio M., Dennis J.W. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 1991, 51:718-723.
18. Takano R., Nose M., Nishihira T., Kyogoku M. Increase of beta 1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am. J. Pathol. 1990, 137:1007-1011.
19. Przybylo M., Martuszewska D., Pochec E., Hoja-Lukowicz D., Litynska A. Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis. Biochim. Biophys. Acta 2007, 1770:1427-1435.
20. Poste G., Doll J., Hart I.R., Fidler I.J. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res. 1980, 40:1636-1644.
21. Reddy B.V., Kalraiya R.D. Sialilated beta1,6 branched N-oligosaccharides modulate adhesion, chemotaxis and motility of melanoma cells: effect on invasion and spontaneous metastasis properties. Biochim. Biophys. Acta 2006, 1760:1393-1402.
22. Demetriou M., Nabi I.R., Coppolino M., Dedhar S., Dennis J.W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol. 1995, 130:383-392.
23. Guo H.B., Lee I., Kamar M., Akiyama S.K., Pierce M. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res. 2002, 62:6837-6845.
24. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc. Natl. Acad. Sci. USA 1995, 92:8754-8758.
25. Margadant C., Monsuur H.N., Norman J.C., Sonnenberg A. Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol. 2011, 23:607-614.
26. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
27. Luo B.H., Springer T.A. Integrin structures and conformational signaling. Curr. Opin. Cell Biol. 2006, 18:579-586.
28. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J. Cell Sci. 2001, 114:4143-4151.
29. Zoller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat. Rev. Cancer 2009, 9:40-55.
30. Hemler M.E. Targeting of tetraspanin proteins-potential benefits and strategies. Nat. Rev. Drug Discov. 2008, 7:747-758.
31. Devbhandari R.P., Shi G.M., Ke A.W., Wu F.Z., Huang X.Y., Wang X.Y., Shi Y.H., Ding Z.B., Xu Y., Dai Z., Fan J., Zhou J. Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin beta1 complex in the progression of hepatocellular carcinoma. PLoS One 2011, 6:e24901.
32. Stipp C.S. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev. Mol. Med. 2010, 12:e3.
33. Bass R., Werner F., Odintsova E., Sugiura T., Berditchevski F., Ellis V. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82. J. Biol. Chem. 2005, 280:14811-14818.
34. Richardson M.M., Jennings L.K., Zhang X.A. Tetraspanins and tumor progression. Clin. Exp. Metastasis 2011, 28:261-270.
35. Ono M., Handa K., Withers D.A., Hakomori S. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells. Biochem. Biophys. Res. Commun. 2000, 279:744-750.
36. Srinivasan N., Bane S.M., Ahire S.D., Ingle A.D., Kalraiya R.D. Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3. Glycoconj. J. 2009, 26:445-456.
37. Krishnan V., Bane S.M., Kawle P.D., Naresh K.N., Kalraiya R.D. Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin. Exp. Metastasis 2005, 22:11-24.
38. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 1977, 83:346-356.
39. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
40. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979, 76:4350-4354.
41. Lagana A., Goetz J.G., Cheung P., Raz A., Dennis J.W., Nabi I.R. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol. Cell. Biol. 2006, 26:3181-3193.
42. Palecek S.P., Loftus J.C., Ginsberg M.H., Lauffenburger D.A., Horwitz A.F. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 1997, 385:537-540.
43. Leppa S., Heino J., Jalkanen M. Increased glycosylation of beta 1 integrins affects the interaction of transformed S115 mammary epithelial cells with laminin-1. Cell Growth Differ. 1995, 6:853-861.
44. Zheng M., Fang H., Hakomori S. Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. J. Biol. Chem. 1994, 269:12325-12331.
45. Isaji T., Sato Y., Zhao Y., Miyoshi E., Wada Y., Taniguchi N., Gu J. N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function. J. Biol. Chem. 2006, 281:33258-33267.
46. Isaji T., Gu J., Nishiuchi R., Zhao Y., Takahashi M., Miyoshi E., Honke K., Sekiguchi K., Taniguchi N. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279:19747-19754.
47. Wang L., Liang Y., Li Z., Cai X., Zhang W., Wu G., Jin J., Fang Z., Yang Y., Zha X. Increase in beta1-6 GlcNAc branching caused by N-acetylglucosaminyltransferase V directs integrin beta1 stability in human hepatocellular carcinoma cell line SMMC-7721. J. Cell. Biochem. 2007, 100:230-241.
48. Velling T., Collo G., Sorokin L., Durbeej M., Zhang H., Gullberg D. Distinct alpha 7A beta 1 and alpha 7B beta 1 integrin expression patterns during mouse development: alpha 7A is restricted to skeletal muscle but alpha 7B is expressed in striated muscle, vasculature, and nervous system. Dev. Dyn. 1996, 207:355-371.
49. Ziober B.L., Chen Y.Q., Ramos D.M., Waleh N., Kramer R.H. Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ. 1999, 10:479-490.
50. Chammas R., Veiga S.S., Travassos L.R., Brentani R.R. Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions. Proc. Natl. Acad. Sci. USA 1993, 90:1795-1799.
51. Mierke C.T., Frey B., Fellner M., Herrmann M., Fabry B. Integrin alpha5beta1 facilitates cancer cell invasion through enhanced contractile forces. J. Cell Sci. 2011, 124:369-383.
52. Kim L.T., Ishihara S., Lee C.C., Akiyama S.K., Yamada K.M., Grinnell F. Altered glycosylation and cell surface expression of beta 1 integrin receptors during keratinocyte activation. J. Cell Sci. 1992, 103(Pt. 3):743-753.
53. Jackson P., Kingsley E.A., Russell P.J. Inverse correlation between KAI1 mRNA levels and invasive behaviour in bladder cancer cell lines. Cancer Lett. 2000, 156:9-17.
54. Serru V., Le Naour F., Billard M., Azorsa D.O., Lanza F., Boucheix C., Rubinstein E. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem. J. 1999, 340(Pt. 1):103-111.
55. Davis T.L., Rabinovitz I., Futscher B.W., Schnolzer M., Burger F., Liu Y., Kulesz-Martin M., Cress A.E. Identification of a novel structural variant of the alpha 6 integrin. J. Biol. Chem. 2001, 276:26099-26106.
56. Demetriou M.C., Pennington M.E., Nagle R.B., Cress A.E. Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp. Cell Res. 2004, 294:550-558.
57. Chu Y.W., Runyan R.B., Oshima R.G., Hendrix M.J. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA 1993, 90:4261-4265.
58. Zhao Y., Nakagawa T., Itoh S., Inamori K., Isaji T., Kariya Y., Kondo A., Miyoshi E., Miyazaki K., Kawasaki N., Taniguchi N., Gu J. N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J. Biol. Chem. 2006, 281:32122-32130.
59. Baldwin G., Novitskaya V., Sadej R., Pochec E., Litynska A., Hartmann C., Williams J., Ashman L., Eble J.A., Berditchevski F. Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin. J. Biol. Chem. 2008, 283:35445-35454.